Evidence map›Paper›PMID 41093929›Full record

ArticleScientific reports2025

Efficient hybrid fuzzy weighted 3D FCNN with TSO PSO optimization for accurate multi modal MRI brain tumor classification.

Liu Feng, Guo Hao, Wang Jian

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Liu FengShanxi Medical University, Fenyang College, Fenyang, 032200, Shanxi, People's Republic of China.
Guo HaoShanxi Medical University, Fenyang College, Fenyang, 032200, Shanxi, People's Republic of China.
Wang JianShanxi Medical University, Fenyang College, Fenyang, 032200, Shanxi, People's Republic of China. wangjiana7549@outlook.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Detecting and segmenting brain tumors from 3D MRI images is a challenging and time-intensive task for clinicians. This research introduces an innovative hybrid architecture for deep learning, comprising a 3D fully convolutional neural network (3D-FCNN), an interval type-2 fuzzy weighting system, and a hybrid transit search optimization-particle swarm optimization (Hybrid-TSO-PSO) algorithm. The proposed models, 3D-FCNN-Hybrid-TSO-PSO and 3D-FCNN-SVM, employ type-2 fuzzy weighting to diminish the quantity of trainable parameters and expedite training on MRI volumetric data. The Hybrid-TSO-PSO optimization approach integrates the heuristic strengths of TSO with the rapid convergence attributes of PSO, enhancing learning stability and augmenting the precision of segmentation and classification. Assessments were conducted on the BraTS 2019, BraTS 2020, and a portion of the BraTS 2021 datasets, comprising 300 3D MRI images (230 high-grade HGG and 70 low-grade LGG glioma specimens). During the testing phase, the 3D-FCNN-Hybrid-TSO-PSO model attained an accuracy of 98.1%, sensitivity of 98.9%, specificity of 95.0%, and a Dice score of 0.987, whereas the 3D-FCNN-SVM model earned an accuracy of 95.2%. This method not only enhances accuracy but also decreases training duration by as much as sixfold relative to traditional architectures, serving as an efficient and precise diagnostic aid for the identification and classification of brain cancers.

Indexed as

Brain NeoplasmsGliomaImaging, Three-DimensionalMagnetic Resonance ImagingNeural Networks, ComputerAlgorithmsDeep LearningFuzzy LogicHumansBrain tumor segmentationComputer aided diagnosisConvolutional neural networksFuzzy logic systemsTransit search algorithm

Identifiers

PMID41093929
PMCPMC12528745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.